Patients' Perception of Follow-Up Care and Personal Health Status of 677 Long-Term Survivors of Gynecological Cancer from the Study "Expression IX-Long-Term Survival with Gynecological Cancer": The International NOGGO, ENGOT and GCIG Survey.
Options
BORIS DOI
Publisher DOI
PubMed ID
42193006
Description
Background: Long-term survivors (LTS) after gynecological cancer may be cured but still face physical and psychological challenges. This multicenter study aimed to assess the long-term side effects, the received follow-up care, and the personal perspectives of survivors. Methods: Between 2019 and 2025, LTS from four European countries within the ENGOT (European Network of Gynecological Oncological Trial Groups) and GCIG (Gynecologic Cancer InterGroup) networks were recruited. Long-term survival was defined as surviving at least five years after the first diagnosis. LTS completed a questionnaire with 81 questions (patient's characteristics, oncological history, current health status, lifestyle factors). Analyses were mainly descriptive. Results: A total of 677 LTS were enrolled, with a median age of 64.0 years (range: 26-92) and a median survival time of 7 years (range: 5-38). A total of 46.6% were diagnosed with cervical cancer, 32.9% with endometrial cancer, 4.4% with ovarian cancer, and 16.1% with other types of gynecological cancer. Moreover, 36.9% still suffer from physical and psychological symptoms, most frequently being lymphedema (36.2%), hot flashes (22.4%), difficulties with concentration (21.1%), fatigue (20.9%), vaginal dryness (20.1%), and urinary incontinence (18.9%). Median overall health status was ranked (scale 1-5; 1 = very good, 5 = very poor) as 2, while 13.5% rated their health as poor/very poor. Current symptoms were associated with poorer health status (p < 0.001) and a history of recurrent disease (p = 0.001). In addition, 13.6% reported not receiving follow-up care. CA-125 was determined in 80.8% of ovarian LTS, as well as in 30.7% of cervical and 28.9% of endometrial LTS. Pap smear follow-up was reported by 50.5% of endometrial LTS. A total of 33.7% did not exercise at all or exercised less than an hour per week, 13.4% smoke tobacco, and 51.2% drink alcohol more often than once a month. Conclusions: Our findings highlight the need for patient-centered follow-up care, addressing both long-term side effects and education on lifestyle and prevention. Follow-up procedures that do not follow guidelines should be avoided.
Date of Publication
2026-05-20
Publication Type
Article
Subject(s)
Keyword(s)
cancer survivorship
•
gynecological cancer
•
long-term side effects
•
long-term survivors
•
secondary cancer
Language(s)
en
Contributor(s)
Woopen, Hannah | |
Zwimpfer, Tibor | |
Brenner, Luise | |
Liebrich, Clemens | |
Leitner, Katharina | |
Henry, Stephanie | |
Müller, Cornelia | |
Ebner, Christoph | |
Mang, Claudia | |
Himsl, Isabelle | |
Hell-Teutsch, Johanna | |
Van Gorp, Toon | |
Nurhayat, Yurtcu | |
Hanker, Lars | |
Heinzelmann-Schwarz, Viola | |
Sehouli, Jalid |
Additional Credits
Series
Cancers
Publisher
MDPI
ISSN
2072-6694
Access(Rights)
open.access